177 related articles for article (PubMed ID: 24588075)
1. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.
Maybury CM; Samarasekera E; Douiri A; Barker JN; Smith CH
Br J Dermatol; 2014 Jun; 170(6):1237-47. PubMed ID: 24588075
[TBL] [Abstract][Full Text] [Related]
2. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.
Maybury CM; Jabbar-Lopez ZK; Wong T; Dhillon AP; Barker JN; Smith CH
Br J Dermatol; 2014 Jul; 171(1):17-29. PubMed ID: 24606161
[TBL] [Abstract][Full Text] [Related]
4. Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.
van den Reek JMPA; Menting SP; Janssen WWL; Dhaliwal R; Heijboer AC; van Herwaarden AE; Sweep FCGJ; de Jong LM; Tjwa ET; Otero ME; Spuls PI; de Jong EMGJ
Br J Dermatol; 2017 Nov; 177(5):1454-1457. PubMed ID: 28112796
[No Abstract] [Full Text] [Related]
5. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
[TBL] [Abstract][Full Text] [Related]
6. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
Khan S; Subedi D; Chowdhury MM
Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
[TBL] [Abstract][Full Text] [Related]
8. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
Zachariae H; Heickendorff L; Søgaard H
Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
[TBL] [Abstract][Full Text] [Related]
10. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
11. Liver biopsies and methotrexate: a time for reconsideration?
Zachariae H
J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
[No Abstract] [Full Text] [Related]
12. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
Thomas JA; Aithal GP
Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
[TBL] [Abstract][Full Text] [Related]
13. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
Zachariae H
Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
[No Abstract] [Full Text] [Related]
14. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
[TBL] [Abstract][Full Text] [Related]
15. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
[TBL] [Abstract][Full Text] [Related]
16. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate for psoriasis in the era of biological therapy.
Warren RB; Chalmers RJ; Griffiths CE; Menter A
Clin Exp Dermatol; 2008 Aug; 33(5):551-4. PubMed ID: 18801095
[TBL] [Abstract][Full Text] [Related]
18. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.
Montaudié H; Sbidian E; Paul C; Maza A; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP
J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():12-8. PubMed ID: 21388454
[TBL] [Abstract][Full Text] [Related]
20. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
